June 2011 Volume 7, Issue 6
Volume 7, Issue 6 | June 2011
June 2011
In this Issue
Research & Development
One for the history books
In its largest acquisition to date, Johnson & Johnson acquires medical device maker Synthes for $21.3 billion, creating the world’s largest orthopedics businessRight fit, right time
Alkermes and Élan Drug Technologies announce $960 million merger, creating leader in CNS therapeuticsWhat's Next(erone) for Baxter?
Pharma giant acquires Ligand partner Prism to bring Nexterone, an anti-arrhythmic agent, to marketBBB and beyond
Lilly, Medtronic collaborate on crossing blood brain barrier to combat Parkinson’s diseaseStriking a ‘cord’ with spinal injuries
InVivo, UMiami collaboration to combine SCI technologies for treatmentInstruments & Informatics
Two’s a cloud
PerkinElmer acquires Geospiza, a leading developer of cloud computing softwareImaging is everything
GE Healthcare to acquire cellular imaging company Applied Precision as part of its life-science expansion plansAvantor acquires POCH from Kulczyk Holding
Acquisition of Poland’s leading performance materials supplier will expand Avantor’s laboratory offering and manufacturing footprint in Eastern EuropeLicense to drive
Sigma Life Science commercializes technology from King’s College London that eases miRNA target identification bottlenecksThe future of work
Cognizant, Eagle Genomics work with Pistoia Alliance to develop cloud-based platform to streamline sequencing servicesOmics & Systems Biology
Playing by the Rules
Myriad acquires Austin-based Rules- Based Medicine for $80 million, boosting capabilities in biomarker discoveryTaking the path of least resistance
Gene-editing collaboration to fight EGFR- targeted therapy resistanceSurf’s up for microRNAs
Regulus Therapeutics, UCSD collaborate on angiogenic disease research utilizing microRNA technologyWet or dry, hope for the eye
Tufts researchers find protein CD59 is key to slowing age-related macular degenerationCreating cancer for the greater good
Researchers make normal stem cells into cancer stem cells and achieve important insights into triple-negative breast cancerEditor's Focus
Will open access open a Pandora’s box for scientific journals?
Should the content in scientific journals be made available to the public? There are unintended consequences to opening up copyrighted material, as evidenced by the many challenges facing the journalism business since Al Gore 'invented' the Internet.Commentary
New tools take time
It’s been a rough first half in 2011, but beneath the noise, much progress is being made, and the last five years have been a lot more productive than we take time to realize.Guest Commentary: Generating more knowledge from data and more value from studies
The nature of drug discovery and development remains an information-rich endeavor, and in order to increase success rates, we must make better use of our data—and our information science experts.Global News
Back to school
Swiss developer Debiopharm and Yale in licensing deal on inhibitor for autoimmune and inflammatory diseasesTaking cancer to TASQ
Active Biotech and Ipsen partner on Tasquinimod TASQ compound in uro-oncologyOnce-in-a-decade breakthrough
Alnylam and Precision NanoSystems form RNAi delivery collaborationA helping hand in India
Swedish pharma Karo Bio and Indian pharma Alkem Laboratories Ltd. to develop eprotirome for dyslipidemiaDiagnostics
Alzheimer’s disease: First steps to stem the epidemic
AD guidelines updated for the first time in decades; NIH-supported revision also proposes staging of disease, potential use of biomarkersA wide spectrum narrows
SynapDx licenses autism diagnostic discoveries from Children’s Hospital BostonMultiplex makes for a magnetic attraction
Applied BioCode announces strategic technology partnership, license agreement with EraGen BiosciencesIn NARMS way
Magellan Biosciences and miacom diagnostics partner to speed up identification of pathogens, streamline lab workflow and enable better treatment decisionsContract Services
Controlling their own destiny
Nautic Partners acquires Omnicare’s CRO armEntrée into the Orient
Mitsui acquires MBS and expands geographic baseServing up ‘plate-to-patient’ fare
Quotient Bioresearch and KWS BioTest partner on end-to-end anti-infectives screeningA public-private partnership
Paragon, UMB and Life Technologies to develop stem-cell therapiesFeature
Look at what’s new in D.C.
Program for 2011 BIO International Convention seeks to provide attendees with a well-rounded knowledge base they can use to advance business objectives
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Thermo Scientific™ Centrifuges with GreenCool Technology
Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.
The crucial role of sample preparation in biotherapy manufacturing
Discover how better sample preparation can unlock improved assay accuracy and analytical results.
Discovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
